Cephalexin - Revision history

Danbot: Remove disease-specific entries now covered by AntibioticDose (3 sections)

2026-03-20T11:08:08Z

Remove disease-specific entries now covered by AntibioticDose (3 sections)

← Revisión anterior		Revisión del 11:08 20 mar 2026
Línea 28:		Línea 28:
	*Max: 500mg/dose		*Max: 500mg/dose

	~~===[[Otitis Media]]===~~
	*75-100mg/kg/day PO divided q12h x 10 days
	*Max: 4,000mg/24h

	~~===Community Acquired [[Pneumonia (Peds)\|Pneumonia]] (>3 Months)===~~
	*75-100mg/kg/day PO divided q12h x 10 days

	~~===Streptococcal [[Pharyngitis]] (>1 Year)===~~
	*40mg/kg/day PO divided q12h x 10 days
	*Max: 500mg/dose

	===Skin Infections===		===Skin Infections===

Danbot: Remove disease-specific dosing covered by dynamic SMW tables

2026-03-20T02:57:47Z

Remove disease-specific dosing covered by dynamic SMW tables

@@ Línea 10: / Línea 10: @@
 *250-500mg PO q6h
 *Max: 4g/day
 ===Indications by Disease===

Danbot: Restore original dosing content alongside dynamic SMW tables

2026-03-20T02:37:36Z

Restore original dosing content alongside dynamic SMW tables

← Revisión anterior		Revisión del 02:37 20 mar 2026
Línea 7:		Línea 7:

	==Adult Dosing==		==Adult Dosing==
			===General===
			*250-500mg PO q6h
			*Max: 4g/day

			===[[Strep Pharyngitis]]===
			*500mg PO q12h x 10 days

			===Uncomplicated [[UTI]]===
			*500mg PO q12h x 7-14 days

			===[[Cellulitis]] and Other Skin Infections===
			*60-120 kg: 500 mg Q6H 1 gram Q8H.
			*>120 kg: 1 g Q6H. <ref>Reduction of Inappropriate Antibiotic Use and Improved Outcomes by Implementation of an Algorithm-Based Clinical Guideline for Nonpurulent Skin and Soft Tissue Infections. Ann Emerg Med. 2020 Feb 13. pii: S0196-0644(19)31453-2. doi: 10.1016/j.annemergmed.2019.12.012. [Epub ahead of print]</ref>


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Cephalexin]] [[Has Population::Adult]]		{{#ask: [[Has DrugName::Cephalexin]] [[Has Population::Adult]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

	==Pediatric Dosing==		==Pediatric Dosing==
			===General===
			*25-50mg/kg/day PO divided q6-12h
			*Max: 500mg/dose

			===[[Otitis Media]]===
			*75-100mg/kg/day PO divided q12h x 10 days
			*Max: 4,000mg/24h

			===Community Acquired [[Pneumonia (Peds)\|Pneumonia]] (>3 Months)===
			*75-100mg/kg/day PO divided q12h x 10 days

			===Streptococcal [[Pharyngitis]] (>1 Year)===
			*40mg/kg/day PO divided q12h x 10 days
			*Max: 500mg/dose

			===Skin Infections===
			*25-50mg/kg/day PO divided q12h
			*Max: 500mg/dose


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Cephalexin]] [[Has Population::Pediatric]]		{{#ask: [[Has DrugName::Cephalexin]] [[Has Population::Pediatric]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

Danbot: Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

2026-03-20T01:52:22Z

Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

← Revisión anterior		Revisión del 01:52 20 mar 2026
Línea 7:		Línea 7:

	==Adult Dosing==		==Adult Dosing==
	===~~General~~===		===Indications by Disease===
	*250-500mg PO q6h		{{#ask: [[Has DrugName::Cephalexin]] [[Has Population::Adult]]
	*Max: ~~4g/day~~		\|?Treats disease=Disease
			\|?Has Dose=Dose
	~~===~~[[~~Strep Pharyngitis~~]]~~===~~		\|?Has Context=Context
	*500mg PO q12h x 10 days		\|format=table
			\|limit=50
	~~===Uncomplicated~~ [[~~UTI~~]]===		\|mainlabel=-
	*500mg PO q12h x 7-14 days		\|headers=show
			\|sort=Treats disease
	===~~[[Cellulitis]] and Other Skin Infections===~~		}}
	*60-120 kg: 500 mg Q6H 1 gram Q8H.
	*>120 kg: 1 g Q6H. <ref>Reduction of Inappropriate Antibiotic Use and Improved Outcomes by Implementation of an Algorithm-Based Clinical Guideline for Nonpurulent Skin and Soft Tissue Infections. Ann Emerg Med. 2020 Feb 13. pii: S0196-0644(19)31453-2. doi: 10.1016/j.annemergmed.2019.12.012. [Epub ahead of print]</ref>

	==Pediatric Dosing==		==Pediatric Dosing==
	===~~General~~===		===Indications by Disease===
	*25-50mg/kg/day PO divided q6-12h		{{#ask: [[Has DrugName::Cephalexin]] [[Has Population::Pediatric]]
	*Max: ~~500mg/dose~~		\|?Treats disease=Disease
			\|?Has Dose=Dose
	~~===~~[[~~Otitis Media~~]]~~===~~		\|?Has Context=Context
	*75-100mg/kg/day PO divided q12h x 10 days		\|format=table
	*Max: ~~4,000mg/24h~~		\|limit=50
			\|mainlabel=-
	===~~Community Acquired [[Pneumonia (Peds)~~\|~~Pneumonia]] (>3 Months)=~~==		\|headers=show
	*75-~~100mg/kg/day PO divided q12h x 10 days~~		\|sort=Treats disease
			}}
	~~===Streptococcal [[Pharyngitis]] (>1 Year)==~~=
	*40mg/kg/day PO divided q12h x 10 days
	*Max: 500mg/dose

	~~===Skin Infections==~~=
	*25-50mg/kg/day PO divided q12h
	*Max: 500mg/dose

	==Special Populations==		==Special Populations==

Ostermayer at 16:08, 18 July 2025

2025-07-18T16:08:10Z

← Revisión anterior		Revisión del 16:08 18 jul 2025
Línea 1:		Línea 1:
	==General==		==General==
	*Type: 1st generation [[Is DrugClass::cephalosporin]]		*Type: [[Is Generation::1st generation]] [[Is DrugClass::cephalosporin]]
	*Dosage forms		*Dosage forms
	**Tabs: 250mg, 500mg, 750mg		**Tabs: 250mg, 500mg, 750mg

Ostermayer at 14:56, 18 July 2025

2025-07-18T14:56:52Z

← Revisión anterior		Revisión del 14:56 18 jul 2025
Línea 1:		Línea 1:
	==General==		==General==
	*Type: 1st generation [[cephalosporin]]		*Type: 1st generation [[Is DrugClass::cephalosporin]]
	*Dosage forms		*Dosage forms
	**Tabs: 250mg, 500mg, 750mg		**Tabs: 250mg, 500mg, 750mg

Rossdonaldson1: /* Cellulitis and Other Skin Infections */

2020-05-08T23:48:50Z

Cellulitis and Other Skin Infections

← Revisión anterior		Revisión del 23:48 8 may 2020
Línea 18:		Línea 18:

	===[[Cellulitis]] and Other Skin Infections===		===[[Cellulitis]] and Other Skin Infections===
	*60-120 kg: 500 mg Q6H 1 gram Q8H. >120 kg: 1 g Q6H. <ref>Reduction of Inappropriate Antibiotic Use and Improved Outcomes by Implementation of an Algorithm-Based Clinical Guideline for Nonpurulent Skin and Soft Tissue Infections. Ann Emerg Med. 2020 Feb 13. pii: S0196-0644(19)31453-2. doi: 10.1016/j.annemergmed.2019.12.012. [Epub ahead of print]</ref>		*60-120 kg: 500 mg Q6H 1 gram Q8H.
			*>120 kg: 1 g Q6H. <ref>Reduction of Inappropriate Antibiotic Use and Improved Outcomes by Implementation of an Algorithm-Based Clinical Guideline for Nonpurulent Skin and Soft Tissue Infections. Ann Emerg Med. 2020 Feb 13. pii: S0196-0644(19)31453-2. doi: 10.1016/j.annemergmed.2019.12.012. [Epub ahead of print]</ref>

	==Pediatric Dosing==		==Pediatric Dosing==

Hoxbox: /* Adult Dosing */

2020-03-05T15:45:20Z

Adult Dosing

← Revisión anterior		Revisión del 15:45 5 mar 2020
Línea 18:		Línea 18:

	===[[Cellulitis]] and Other Skin Infections===		===[[Cellulitis]] and Other Skin Infections===
	*~~500mg to 1g PO q12h, shown to be as effective as qid dosing~~.<ref>~~Browning, AK~~. ~~The efficacy of twice daily cephalexin~~. ~~Pharmatherapeutica~~. ~~1981;2~~(9):~~559-64~~.</ref>		*60-120 kg: 500 mg Q6H 1 gram Q8H. >120 kg: 1 g Q6H. <ref>Reduction of Inappropriate Antibiotic Use and Improved Outcomes by Implementation of an Algorithm-Based Clinical Guideline for Nonpurulent Skin and Soft Tissue Infections. Ann Emerg Med. 2020 Feb 13. pii: S0196-0644(19)31453-2. doi: 10.1016/j.annemergmed.2019.12.012. [Epub ahead of print]</ref>

	==Pediatric Dosing==		==Pediatric Dosing==

Gpowellhb: /* Cellulitis and Other Skin Infections */

2020-02-15T15:09:14Z

Cellulitis and Other Skin Infections

← Revisión anterior		Revisión del 15:09 15 feb 2020
Línea 18:		Línea 18:

	===[[Cellulitis]] and Other Skin Infections===		===[[Cellulitis]] and Other Skin Infections===
	*500mg PO q12h		*500mg to 1g PO q12h, shown to be as effective as qid dosing.<ref>Browning, AK. The efficacy of twice daily cephalexin. Pharmatherapeutica. 1981;2(9):559-64.</ref>

	==Pediatric Dosing==		==Pediatric Dosing==

ClaireLewis: /* References */

2019-09-19T22:04:48Z

References

← Revisión anterior		Revisión del 22:04 19 sep 2019
Línea 228:		Línea 228:
	*Lexicomp		*Lexicomp

	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:ID]]